NasdaqGS - Delayed Quote • USD
Bruker Corporation (BRKR)
At close: April 24 at 4:00 PM EDT
After hours: April 24 at 5:44 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 10 | 9 | 11 | 11 |
| Avg. Estimate | 0.46 | 0.56 | 2.71 | 3.39 |
| Low Estimate | 0.45 | 0.46 | 2.5 | 3.14 |
| High Estimate | 0.49 | 0.61 | 2.76 | 3.55 |
| Year Ago EPS | 0.64 | 0.5 | 2.68 | 2.71 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 10 | 9 | 10 | 10 |
| Avg. Estimate | 729.88M | 764.06M | 3.28B | 3.53B |
| Low Estimate | 717M | 749.64M | 3.25B | 3.44B |
| High Estimate | 742.11M | 780.9M | 3.45B | 3.84B |
| Year Ago Sales | 685.3M | 681.9M | 2.96B | 3.28B |
| Sales Growth (year/est) | 6.50% | 12.00% | 10.70% | 7.50% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 0.55 | 0.48 | 0.63 | 0.68 |
| EPS Actual | 0.64 | 0.5 | 0.74 | 0.8 |
| Difference | 0.09 | 0.02 | 0.11 | 0.12 |
| Surprise % | 16.40% | 4.20% | 17.50% | 17.60% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.46 | 0.56 | 2.71 | 3.39 |
| 7 Days Ago | 0.46 | 0.57 | 2.73 | 3.41 |
| 30 Days Ago | 0.46 | 0.57 | 2.74 | 3.44 |
| 60 Days Ago | 0.46 | 0.57 | 2.74 | 3.44 |
| 90 Days Ago | 0.61 | 0.6 | 2.77 | 3.16 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | 1 |
| Up Last 30 Days | -- | -- | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 1 | 1 | 2 | 2 |
Growth Estimates
| CURRENCY IN USD | BRKR | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -28.10% | -- | -- | 1.50% |
| Next Qtr. | 12.00% | -- | -- | 11.40% |
| Current Year | 1.10% | -- | -- | 5.20% |
| Next Year | 25.10% | -- | -- | 13.40% |
| Next 5 Years (per annum) | 14.15% | -- | -- | 11.09% |
| Past 5 Years (per annum) | 18.36% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Goldman Sachs: Sell to Sell | 4/10/2024 |
| Maintains | UBS: Buy to Buy | 3/1/2024 |
| Maintains | UBS: Buy to Buy | 2/15/2024 |
| Maintains | Citigroup: Buy to Buy | 2/14/2024 |
| Maintains | Stifel: Hold to Hold | 2/14/2024 |
| Upgrade | JP Morgan: Neutral to Overweight | 2/14/2024 |
Related Tickers
BIO Bio-Rad Laboratories, Inc.
278.21
-2.48%
CNMD CONMED Corporation
70.01
-1.82%
INSP Inspire Medical Systems, Inc.
234.19
+0.11%
IART Integra LifeSciences Holdings Corporation
29.38
0.00%
QDEL QuidelOrtho Corporation
40.82
+1.04%
EW Edwards Lifesciences Corporation
88.61
+0.98%
NARI Inari Medical, Inc.
38.18
+2.88%
CTKB Cytek Biosciences, Inc.
5.66
-2.58%
PODD Insulet Corporation
167.25
-0.01%
QTRX Quanterix Corporation
16.04
-0.37%